Belfer Institute, Sanofi-Aventis Partner on Oncology Targets
September 24, 2010
Belfer Institute, Sanofi-Aventis Partner on Oncology Targets
The institute and the drugmaker will collaborate to identify and validate oncology targets, and Sanofi-Aventis will then do further work to develop therapeutic agents against the targets and related biomarkers.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.